LVIS Corporation
Neural information analysis technology decoding brain networks for advanced neurological disease diagnosis.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
$15.0m | Series B | ||
| Total Funding | 000k | ||
LVIS Corporation is a pioneering company in the field of neural information analysis technology, focusing on decoding brain networks to assist in the diagnosis of neurological diseases. The company operates in the healthcare sector, specifically targeting neurological healthcare. LVIS serves medical professionals and institutions that require advanced tools for examining and diagnosing neurological conditions. The business model revolves around the development and deployment of cutting-edge EEG (electroencephalogram) software, which provides detailed visualizations of brain activity. LVIS makes money through the sale and licensing of its software solutions, as well as through partnerships and collaborations with healthcare providers. The company is currently inviting select medical professionals to join its NeuroMatch Ambassador Program, which offers early access to its state-of-the-art EEG software for beta testing and feedback. This initiative aims to fine-tune the software to meet the high standards and specific demands of medical practices, ensuring its effectiveness and reliability in real-world applications.
Keywords: neural analysis, brain networks, EEG software, neurological diagnosis, healthcare technology, medical professionals, NeuroMatch, beta testing, innovation, brain activity visualization.